Skip to main content
. 2021 Mar 19;51(8):1287–1297. doi: 10.1093/jjco/hyab028

Table 3.

Non-haematological adverse events occurring in ≥5% of patients for any grade and ≥3% of patients for grade ≥ 3

Preferred term n (%) Cabazitaxel (n = 112) Abiraterone or enzalutamide (n = 105)
Any grade Grade ≥ 3 Any grade Grade ≥ 3
 Asthenia or fatigue 62 (55.4) 5 (4.5) 37 (35.2) 1 (1.0)
 Diarrhoea 45 (40.2) 4 (3.6) 6 (5.7) 0
 Infection 36 (32.1) 7 (6.3) 23 (21.9) 7 (6.7)
 Musculoskeletal pain or discomfort* 32 (28.6) 2 (1.8) 38 (36.2) 4 (3.8)
 Nausea or vomiting 30 (26.8) 0 21 (20.0) 1 (1.0)
 Peripheral neuropathy 23 (20.5) 4 (3.6) 3 (2.9) 0
 Haematuria 19 (17.0) 1 (0.9) 6 (5.7) 1 (1.0)
 Constipation 16 (14.3) 0 10 (9.5) 0
 Decreased appetite 16 (14.3) 1 (0.9) 15 (14.3) 3 (2.9)
 Dysgeusia 12 (10.7) 0 4 (3.8) 0
 Abdominal pain 10 (8.9) 1 (0.9) 3 (2.9) 1 (1.0)
 Bladder or urethral symptom 10 (8.9) 0 6 (5.7) 0
 Peripheral edema 10 (8.9) 0 8 (7.6) 1 (1.0)
 Cancer pain 9 (8.0) 2 (1.8) 8 (7.6) 1 (1.0)
 Stomatitis 9 (8.0) 0 1 (1.0) 0
 Pain 8 (7.1) 0 5 (4.8) 1 (1.0)
 Renal disorder§ 7 (6.3) 3 (2.7) 12 (11.4) 9 (8.6)
 Alopecia 6 (5.4) 0 0 0
 Arthralgia 6 (5.4) 0 14 (13.3) 1 (1.0)
 Dyspepsia 6 (5.4) 0 2 (1.9) 0
 Fall 6 (5.4) 0 0 0
 Paraesthesia 6 (5.4) 0 2 (1.9) 0
 Pyrexia 6 (5.4) 0 9 (8.6) 0
 Spinal cord or nerve-root disorder|| 6 (5.4) 3 (2.7) 5 (4.8) 3 (2.9)
 Hypertensive disorder 5 (4.5) 3 (2.7) 9 (8.6) 2 (1.9)
 Psychiatric disorder†† 5 (4.5) 0 13 (12.4) 0
 Weight decreased 5 (4.5) 0 7 (6.7) 0
 Cardiac disorder 4 (3.6) 1 (0.9) 8 (7.6) 5 (4.8)
 Disease progression 4 (3.6) 4 (3.6) 8 (7.6) 7 (6.7)
 Febrile neutropenia 4 (3.6) 4 (3.6) 0 0
 Bone fracture 2 (1.8) 1 (0.9) 6 (5.7) 2 (1.9)
 Dizziness 1 (0.9) 0 6 (5.7) 0

*Musculoskeletal pain or discomfort included ‘Back pain’, ‘Flank pain’, ‘Musculoskeletal discomfort’, ‘Musculoskeletal pain’, ‘Discomfort’,

‘Neck pain’, ‘Pain in extremity’, ‘Growing pains’, ‘Musculoskeletal chest pain’.

Peripheral Neuropathy included, ‘Neuropathy peripheral’, ‘Peripheral motor neuropathy’, ‘Peripheral sensorimotor neuropathy’, ‘Peripheral sensory neuropathy’, ‘Polyneuropathy’.

Bladder or urethral symptom included ‘Dysuria’, ‘Pollakiuria’, ‘Lower urinary tract symptoms’, ‘Micturition urgency’, ‘Urinary incontinence’, ‘Urinary retention’.

§Renal disorder included, ‘Acute kidney injury’, ‘Renal failure’, ‘Renal impairment’, ‘Hydronephrosis’, ‘Pyelocaliectasis’.

||Spinal cord or nerve-root disorder included ‘Sciatica’, ‘Radiculopathy’, ‘Spinal cord compression’.

Hypertensive disorder included ‘Hypertension’, ‘Hypertensive crisis’.

††Psychiatric disorder included ‘Anxiety’, ‘Depression’, ‘Confusional state’, ‘Disorientation’, ‘Persistent depressive disorder’, ‘Insomnia’.

Note: System organ class was used for infection and cardiac disorders.